Treatment Registry
TR-0218 ActiveRecorded September 2, 2026

Compounded tirzepatide

Sold by Helimeds · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$149

Medication · Starter Dose (12-week supply)$149

Added from the figures recorded below.

Price

TermPer monthCharged today
Starter Dose (12-week supply)

Starter Dose $447 one time payment SAVE $50 $149 / month

source

Per month$149Charged today$447
Any other dose (12-week supply)

Any other dose $697 one time payment SAVE $50 $232 / month

source

Per month$232Charged today$697
Visit Helimeds

We earn nothing from this link. Helimeds has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

PrescriberAsynchronous review
Cancellation“What if I need to cancel? To cancel, contact [email protected] . We offer flexible cancellation with no fees or long-term contract commitments.”

Not yet checked: pharmacy, states, membership and consult fee.

Recorded from helimeds.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026The site's /treatments/semaglutide page is titled 'Compounded GLP-1' and never actually uses the word 'semaglutide' in its visible text, so that product is recorded as unspecified GLP-1 rather than compounded semaglutide -- it does, however, explicitly say the '3 month supply of the medication will arrive in a single vial,' confirming injection-vial. The tirzepatide page never states vial vs pen. Footer branding is 'Travex Inc'; 'Helimeds' is the storefront brand name used throughout the visible copy.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0218
Readings
1

Related records

What else Helimeds sells

All Helimeds programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 307 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Helimeds compounded tirzepatide (TR-0218). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0218

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.